Corneal crosslinking shows favourable long-term outcomes

Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis

Ground-breaking treatment for bullous keratopathy approved in Japan

According to Bausch + Lomb and Novaliq, MIEBO is the first prescription eye drop approved for dry eye disease that directly targets tear evaporation, based on consistent results from a pair of pivotal Phase 3 trials.

The announcement represents the first FDA-approved, fixed-combination of tropicamide and phenylephrine for mydriasis, according to the company.

Physician outlines latest emerging technologies to treat condition

A colourful look at how the keratopigmentation technique offers therapeutic and cosmetic applications.